178 related articles for article (PubMed ID: 20023292)
1. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.
Carlsen SM; Vanky E
Hum Reprod; 2010 Mar; 25(3):786-90. PubMed ID: 20023292
[TBL] [Abstract][Full Text] [Related]
2. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
[TBL] [Abstract][Full Text] [Related]
3. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns.
Vanky E; Carlsen SM
Fertil Steril; 2012 Feb; 97(2):509-15. PubMed ID: 22154766
[TBL] [Abstract][Full Text] [Related]
4. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome.
Caanen MR; Kuijper EA; Hompes PG; Kushnir MM; Rockwood AL; Meikle WA; Homburg R; Lambalk CB
Eur J Endocrinol; 2016 Jan; 174(1):25-32. PubMed ID: 26586837
[TBL] [Abstract][Full Text] [Related]
6. Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin.
Vanky E; Salvesen KA; Carlsen SM
Hum Reprod; 2004 Mar; 19(3):529-33. PubMed ID: 14998946
[TBL] [Abstract][Full Text] [Related]
7. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
8. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
9. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.
Cibula D; Fanta M; Vrbikova J; Stanicka S; Dvorakova K; Hill M; Skrha J; Zivny J; Skrenkova J
Hum Reprod; 2005 Jan; 20(1):180-4. PubMed ID: 15576394
[TBL] [Abstract][Full Text] [Related]
10. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
Horng SG; Wang TH; Wang HS
Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595
[TBL] [Abstract][Full Text] [Related]
11. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
[TBL] [Abstract][Full Text] [Related]
12. Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus.
Andræ F; Abbott D; Stridsklev S; Schmedes AV; Odsæter IH; Vanky E; Salvesen Ø
J Clin Endocrinol Metab; 2020 Dec; 105(12):3762-70. PubMed ID: 32866967
[TBL] [Abstract][Full Text] [Related]
13. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
[TBL] [Abstract][Full Text] [Related]
14. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
[TBL] [Abstract][Full Text] [Related]
15. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM
Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076
[TBL] [Abstract][Full Text] [Related]
17. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
18. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
Carlsen SM; Kjøtrød S; Vanky E; Romundstad P
Acta Obstet Gynecol Scand; 2007; 86(2):145-50. PubMed ID: 17364275
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]